Upfront metronomic chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma | |
He, Xi-Ran1; Du, Yang2; Jin, Yu-Shen2; Bai, Hua1; Tian, Jie2; Wang, Jie1 | |
刊名 | CANCER RESEARCH
![]() |
2020-08-01 | |
卷号 | 80期号:16页码:2 |
ISSN号 | 0008-5472 |
DOI | 10.1158/1538-7445.AM2020-2207 |
WOS研究方向 | Oncology |
语种 | 英语 |
出版者 | AMER ASSOC CANCER RESEARCH |
WOS记录号 | WOS:000590059304235 |
内容类型 | 期刊论文 |
源URL | [http://ir.ia.ac.cn/handle/173211/43183] ![]() |
专题 | 自动化研究所_中国科学院分子影像重点实验室 |
作者单位 | 1.Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China 2.Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China |
推荐引用方式 GB/T 7714 | He, Xi-Ran,Du, Yang,Jin, Yu-Shen,et al. Upfront metronomic chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma[J]. CANCER RESEARCH,2020,80(16):2. |
APA | He, Xi-Ran,Du, Yang,Jin, Yu-Shen,Bai, Hua,Tian, Jie,&Wang, Jie.(2020).Upfront metronomic chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma.CANCER RESEARCH,80(16),2. |
MLA | He, Xi-Ran,et al."Upfront metronomic chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma".CANCER RESEARCH 80.16(2020):2. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论